Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

16:03 ET Infinity Pharmaceuticals Announces Transition of Samuel Agresta, M.D., from Chief Medical Officer to Board of Directors

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that Samuel Agresta, M.D., will transition from his role as Chief Medical Officer to...


13:26 ET Satsuma Pharmaceuticals Announces First Patient Dosed in EMERGE™, a Phase 3 Efficacy Trial of STS101 for the Acute Treatment of Migraine

Satsuma Pharmaceuticals, Inc. ("Satsuma" or "the Company"), a clinical-stage biopharmaceutical company, today announced dosing of the first patient...


12:14 ET AskBio Applauds Pfizer's Continuing Investments in Gene Therapy

In 1978, when a doctoral student named Jude Samulski started a journey of discovery for how the adeno-associated virus (AAV) could be used to safely...


11:59 ET Global Subcutaneous Drug Delivery Market to Surpass US$ 15.8 Billion by 2026

SEATTLE, Aug. 22, 2019 /PRNewswire/ - According to Coherent Market Insights, the global subcutaneous drug delivery market is valued at US$ 7,077.5...


11:22 ET Biotech Conagen adquiere una plataforma de producción de proteínas terapéuticas

Conagen, una empresa de biología sintética integrada verticalmente, situada en el corredor biotecnológico de Boston, ha anunciado hoy la adquisición...


11:00 ET Blue Cross and Blue Shield of Minnesota to Cover Insulin Costs at No Charge Next Year

As part of its broader efforts to reign in health care prices that place a tremendous financial burden on families throughout the state, Blue Cross...


10:29 ET Global Cervical Cancer Vaccines Market to Surpass US$ 6 Billion by 2026

According to Coherent Market Insights, the global cervical cancer vaccines market was valued at US$ 2,595.5 million in 2018, and is projected to...


10:00 ET Grand River Aseptic Manufacturing Ranked on the Inc. 5000 List for Third Consecutive Year

Grand River Aseptic Manufacturing ("GRAM"), a leading parenteral contract development and manufacturing organization, was recently ranked in Inc....


09:30 ET Evofem Biosciences to Present at Upcoming Healthcare Conferences

Evofem Biosciences, Inc., (NASDAQ: EVFM), a clinical-stage biopharmaceutical company, is set to present at two healthcare equity conferences in early ...


09:07 ET TraceLink Demonstrates Continued Global Momentum with Strong Q2 2019 Results

TraceLink Inc., the world's largest integrated digital supply network, providing real-time information sharing for better patient outcomes, today...


08:42 ET Texas-Based Companies Join Forces to Modernize and Simplify Healthcare

Uber changed the way we commute. Amazon changed the way we shop. And now, Reliant Immune Diagnostics' MDBox, along with Texas based grocer H-E-B, is...


08:30 ET Ampio Pharmaceuticals Retains Financial Advisor and Appoints Transaction Advisory Committee

Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) a development stage biopharmaceutical company, executing a special protocol assessment (SPA) phase...


08:30 ET Portola Pharmaceuticals to Participate in Two Upcoming Investor Conferences

Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced that the Company will participate in the following conferences in September. Citi's...


08:00 ET Chinook Therapeutics Raises $65 Million Series A Financing to Advance Precision Medicines for Kidney Diseases

Chinook Therapeutics, Inc. today announced a $65 million Series A financing to discover and develop precision medicines for kidney diseases. Founding ...


08:00 ET CVS Health Corporation Announces Early Results of Maximum Tender Offers and Election of Early Settlement

CVS Health Corporation ("CVS Health", NYSE: CVS) announced today the early results of the previously announced cash tender offers (the "Maximum...


08:00 ET Regulation Needs to Keep Pace With Global Cannabis Legalisation in 2019 - Prohibition Partners

The number of countries to legalise medical cannabis has risen nine-fold in the last five years, as global attitudes towards cannabis have shifted in ...


08:00 ET Erasca Announces Key Leadership Team Appointments and Recruits World-Class Research and Development Advisory Board

Erasca, a company dedicated to advancing exceptional scientific approaches to erase cancer, today announced the promotion of Gary Yeung, CFA, to...


07:48 ET Perrigo To Present At Upcoming Investor Conferences

Perrigo Company plc (NYSE; TASE: PRGO), today announced that CEO and President, Murray S. Kessler and CFO, Ray Silcock, will host one-on-one meetings ...


07:30 ET Biofourmis names two pharmaceutical veterans to leadership team

Biofourmis, a fast-growing global leader in digital therapeutics based in Boston, has added two global pharmaceutical senior executive veterans to...


07:19 ET Biotech Conagen acquiert une plateforme de production de protéines thérapeutiques

Conagen, une société de biologie synthétique verticalement intégrée et établie dans le couloir de la biotechnologie de Boston, a annoncé aujourd'hui...


07:17 ET Das Biotech-Unternehmen Conagen kauft Produktionsplattform für therapeutische Proteine

Conagen, ein im Bostoner Biotech-Korridor angesiedeltes, vertikal integriertes Unternehmen im Bereich synthetische Biologie, gab heute bekannt, dass...


05:00 ET Visiongain Report Offers Transformative Insights on the $33bn Ophthalmic Drugs Market

The global ophthalmic drugs market is expected to grow at a CAGR of 4.8% in the first half of the forecast period. The market is estimated at $25bn...


03:11 ET AlzeCure Publishes its Interim Report for January - June 2019

AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that its interim report for the January - June 2019 is now available on the company's...


03:00 ET Daiichi Sankyo Announces the Presentation of New Data on LIXIANA®▼ (edoxaban) to be Presented at ESC Congress 2019

Daiichi Sankyo Europe GmbH (hereafter, Daiichi Sankyo) today announced clinical results for edoxaban (known by the brand name LIXIANA®▼) will be...


01:16 ET Nordic Nanovector ASA - Results for the Second Quarter and First Half 2019

Nordic Nanovector ASA (OSE: NANO) announces its results for the second quarter and first half 2019. A presentation by the company's senior management ...